Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
613 | 3163 | 29.2 | 72% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
526 | 14150 | JOURNAL OF NUCLEAR CARDIOLOGY//MYOCARDIAL PERFUSION IMAGING//MYOCARDIAL VIABILITY |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | JOURNAL OF NUCLEAR CARDIOLOGY | Journal | 172 | 29% | 16% | 503 |
2 | GATED SPECT | Author keyword | 118 | 56% | 5% | 143 |
3 | MYOCARDIAL PERFUSION IMAGING | Author keyword | 117 | 34% | 9% | 286 |
4 | TRANSIENT ISCHEMIC DILATION | Author keyword | 51 | 91% | 1% | 21 |
5 | REVERSE REDISTRIBUTION | Author keyword | 35 | 74% | 1% | 26 |
6 | QUANTITATIVE GATED SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY | Author keyword | 31 | 92% | 0% | 12 |
7 | GATED SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY | Author keyword | 28 | 56% | 1% | 35 |
8 | TETROFOSMIN | Author keyword | 27 | 49% | 1% | 39 |
9 | MT SINAI CARDIOL MT SINAI HEART | Address | 24 | 91% | 0% | 10 |
10 | MYOCARDIAL PERFUSION IMAGING SPECT | Author keyword | 21 | 51% | 1% | 29 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | TL 201 | 183 | 28% | 17% | 549 |
2 | EMISSION COMPUTED TOMOGRAPHY | 145 | 18% | 24% | 747 |
3 | MYOCARDIAL PERFUSION SPECT | 122 | 43% | 7% | 217 |
4 | INCREMENTAL PROGNOSTIC VALUE | 89 | 36% | 6% | 202 |
5 | TC 99M SESTAMIBI | 86 | 28% | 8% | 264 |
6 | METHOXY ISOBUTYL ISONITRILE | 67 | 72% | 2% | 52 |
7 | SQ30217 | 65 | 93% | 1% | 25 |
8 | HEXAKIS 2 METHOXYISOBUTYL ISONITRILE | 62 | 51% | 3% | 88 |
9 | TECHNETIUM 99M TETROFOSMIN | 51 | 47% | 3% | 82 |
10 | GATED SPECT | 51 | 48% | 2% | 78 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | JOURNAL OF NUCLEAR CARDIOLOGY | 172 | 29% | 16% | 503 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The prognostic value of normal exercise myocardial perfusion imaging and exercise echocardiography - A meta-analysis | 2007 | 179 | 155 | 56% |
Prognostic value of gated myocardial perfusion SPECT | 2004 | 259 | 96 | 57% |
EANM/ESC procedural guidelines for myocardial perfusion imaging in nuclear cardiology | 2005 | 208 | 105 | 46% |
Quantitation in gated perfusion SPECT imaging: The Cedars-Sinai approach | 2007 | 70 | 81 | 89% |
Advances in Cardiac Processing Software | 2014 | 4 | 43 | 67% |
Gated SPECT in assessment of regional and global left ventricular function: Major tool of modern nuclear imaging | 2006 | 30 | 115 | 87% |
Myocardial perfusion scintigraphy: the evidence - A consensus conference organised by the British Cardiac Society, the British Nuclear Cardiology Society and the British Nuclear Medicine Society, endorsed by the Royal College of Physicians of London and the Royal College of Radiologists | 2004 | 185 | 241 | 41% |
Contributions of nuclear cardiology to diagnosis and prognosis of patients with coronary artery disease | 2000 | 214 | 88 | 40% |
Physical attributes, limitations, and future potential for PET and SPECT | 2012 | 12 | 17 | 82% |
EANM/ESC guidelines for radionuclide imaging of cardiac function | 2008 | 63 | 113 | 35% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MT SINAI CARDIOL MT SINAI HEART | 24 | 91% | 0.3% | 10 |
2 | OREGON HEART VASC | 18 | 83% | 0.3% | 10 |
3 | NUCL CARDIOL | 10 | 24% | 1.1% | 36 |
4 | MED CLIN CARDIOL 1 | 6 | 71% | 0.2% | 5 |
5 | RADIOL NUKL MED MOL BILDGEBUNG | 6 | 58% | 0.2% | 7 |
6 | CARDIOVASC NUCL IMAGING | 6 | 50% | 0.3% | 8 |
7 | UP EA 2403 | 4 | 67% | 0.1% | 4 |
8 | CARDIOL C5 | 4 | 75% | 0.1% | 3 |
9 | CARDIOVASCEXPT CARDIOL | 4 | 75% | 0.1% | 3 |
10 | CSMC BURNS ALLEN | 4 | 29% | 0.4% | 12 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000188527 | STRESS ECHOCARDIOGRAPHY//REGADENOSON//ARBUTAMINE |
2 | 0.0000160683 | MYOCARDIAL VIABILITY//HIBERNATING MYOCARDIUM//VIABLE MYOCARDIUM |
3 | 0.0000145284 | D SHAPED LEFT VENTRICLE//SEPTAL FLATTENING//COHERENT FIBER ARRAYS |
4 | 0.0000135832 | MYOCARDIAL BLOOD FLOW//RB 82//NITROGEN 13 AMMONIA |
5 | 0.0000127464 | GATED BLOOD POOL SPECT//GATED BLOOD POOL IMAGING//BLOOD POOL SPECT |
6 | 0.0000120604 | T WAVE NORMALIZATION//ST HR ANALYSIS//ST HR SLOPE |
7 | 0.0000106607 | SCATTER CORRECTION//ATTENUATION CORRECTION//SIMULTANEOUS DUAL ISOTOPE IMAGING |
8 | 0.0000101043 | EXERCISE TL 201 TOMOGRAPHY//NEUROLEPTIC CARDIOMYOPATHY//CARDIOMYOPATHY ISCHEMIC |
9 | 0.0000093517 | APPROPRIATE USE CRITERIA//ACCF APPROPRIATE USE CRITERIA//APPROPRIATE UTILIZATION |
10 | 0.0000088377 | NUCLEAR MEDICINE PRACTICE//NUCL MED SOFTWARE WORKING PARTY//DIAGNOSTIC NUCLEAR MEDICINE |